OnQuality Pharmaceuticals
Shanghai
About OnQuality Pharmaceuticals
OnQuality Pharmaceuticals offers trials to assess the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $35.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2021)
- Website: onqualityrx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/onquality-pharmaceuticals-453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.